Study breaks down Alzheimer’s treatment effects in clear terms

In the past two years, the Food and Drug Administration has approved two novel Alzheimer’s therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Trump’s already gone back on his promise to leave abortion to states

Abortion foes worried before his election that President Donald Trump had moved on, now that Roe v. Wade is overturned and abortion policy, as he

February 5, 2025

Republicans aren’t quite done talking about Obamacare, after all

WASHINGTON — In a far-ranging debate that touched on everything from border control issues to TikTok, Republican presidential candidates could not escape hotly contested health

September 28, 2023

Federal judge rules against Regeneron’s attempt to halt Amgen from launching Eylea biosimilar

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.